PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Standardized Oral Care Cuts Severe Mucositis in Leukemia Induction

oral mucositisstandardized oral care protocolleukemiainduction chemotherapyopioid usemorphine milligram equivalentsparenteral nutritionsupportive careCTCAEretrospective cohortMASCC/ISOO Oncology Pharmacy

Background Information

Standardized oral care cuts severe mucositis in leukemia chemotherapy by nearly half.

Oral mucositis (OM) is a common and painful side effect of chemotherapy, impacting quality of life and treatment adherence. A standardized oral care protocol reduced severe OM from 33.3% to 18.9% and decreased opioid use and OM duration in leukemia patients. This single-center retrospective study suggests a potential protocol to alleviate OM symptoms, but prospective studies are needed to confirm findings. A standardized oral care protocol may significantly reduce OM severity in leukemia patients undergoing chemotherapy.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Yu F, Mao T

Citation: Yu F, Mao T Impact of a standardized oral care protocol on oral mucositis severity in leukemia patients receiving induction chemotherapy. Medicine. 2026;105(38):e50630. doi:10.1097/MD.0000000000050630

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.